The Patent Finder

Rubius Therapeutics, Inc.

Also on record
Records under this name other than the patents Rubius Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Back to Rubius Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,141,433Therapeutic Cell Systems and Methods for Treating Cancer and Infectious Diseases
Lapsed on the fee record
Ended Oct 12, 2025 · High confidence
Lapsed on the fee recordEnded Oct 12, 2025High confidence
US 11,020,435Functionalized Erythroid Cells
Lapsed on the fee record
Ended Jun 1, 2025 · High confidence
Lapsed on the fee recordEnded Jun 1, 2025High confidence
US 9,644,180Synthetic Membrane-Receiver Complexes
Lapsed on the fee record
Ended May 9, 2025 · Medium confidence
Lapsed on the fee recordEnded May 9, 2025Medium confidence
US 10,869,898Methods and Compositions for Immunomodulation
Lapsed on the fee record
Ended Dec 22, 2024 · High confidence
Lapsed on the fee recordEnded Dec 22, 2024High confidence
US 10,716,811Compositions and Methods Related to Multimodal Therapeutic Cell Systems for Cancer Indications
Lapsed on the fee record
Ended Jul 21, 2024 · High confidence
Lapsed on the fee recordEnded Jul 21, 2024High confidence
US 10,568,910Compositions and Methods Related to Engineered Erythroid Cells Comprising IL-15
Lapsed on the fee record
Ended Feb 25, 2024 · High confidence
Lapsed on the fee recordEnded Feb 25, 2024High confidence
US 10,557,119Erythroid Cells Comprising Phenylalanine Ammonia Lyase
Lapsed on the fee record
Ended Feb 11, 2024 · Medium confidence
Lapsed on the fee recordEnded Feb 11, 2024Medium confidence
US 10,517,897Methods Related to Engineered Erythoid Cells Comprising 4-1BBL
Lapsed on the fee record
Ended Dec 31, 2023 · High confidence
Lapsed on the fee recordEnded Dec 31, 2023High confidence
US 10,456,421Compositions and Methods Related to Engineered Erythoid Cells Comprising 4-1BBL
Lapsed on the fee record
Ended Oct 29, 2023 · High confidence
Lapsed on the fee recordEnded Oct 29, 2023High confidence
14/581,486Synthetic Membrane-Receiver Complexes
Abandoned
Abandoned Feb 14, 2017
AbandonedAbandoned Feb 14, 2017
10 of 51 records shown.
Pro members see all 51.
Pro members: see all 51 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited